CAMKMT and neoplasm: Therefore, the combination of a KMT inhibitor with current treatments based on DNA damage in sarcomas, such as ionizing radiation or doxorubicin, could be useful to develop novel strategies that sensitize tumor cells (Figure 11) and, at the same time, might contribute to reduce the dose of these toxic treatments.